J Gen Virol Faster Access
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hill, C. L.
Right arrow Articles by McClure, M. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hill, C. L.
Right arrow Articles by McClure, M. O.
Agricola
Right arrow Articles by Hill, C. L.
Right arrow Articles by McClure, M. O.
Journal of General Virology (1999), 80, 2003-2009.
© 1999 Society for General Microbiology


Animal: RNA Viruses

Properties of human foamy virus relevant to its development as a vector for gene therapy

Claire L. Hill1, Paul D. Bieniaszb,1 and Myra O. McClure1

Department of GU Medicine and Communicable Diseases, Jefferiss Research Trust Laboratories, Imperial College School of Medicine at St. Mary's, Praed Street, London W2 1NY, UK1

Author for correspondence: Myra McClure.Fax +44 20 7886 6648. e-mail m.mcclure{at}ic.ac.uk

The Spumaviridae (foamy viruses) are increasingly being considered as potential vectors for gene therapy, yet little has been documented of their basic cell biology. This study demonstrates that human foamy virus (HFV) has a broad tropism and that the receptor for HFV is expressed not only on many mammalian, but on avian and reptilian cells. Receptor interference assays using an envelope-expressing cell line and a vesicular stomatitis virus/HFV pseudotype virus demonstrate that the cellular receptor is common to all primate members of the genus. The majority of foamy virus particles assemble and remain sequestered intracellularly. A rapid and quantitative method of assaying foamy virus infectivity by reverse transcriptase activity facilitates the use of classical protocols to increase infectious virus titres in vitro to >=106 TCID/ml.




This article has been cited by other articles:


Home page
J. Virol.Home page
I. Mannigel, A. Stange, H. Zentgraf, and D. Lindemann
Correct Capsid Assembly Mediated by a Conserved YXXLGL Motif in Prototype Foamy Virus Gag Is Essential for Infectivity and Reverse Transcription of the Viral Genome
J. Virol., April 1, 2007; 81(7): 3317 - 3326.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. Duda, D. Luftenegger, T. Pietschmann, and D. Lindemann
Characterization of the prototype foamy virus envelope glycoprotein receptor-binding domain.
J. Virol., August 1, 2006; 80(16): 8158 - 8167.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
G. D. Trobridge, D. G. Miller, M. A. Jacobs, J. M. Allen, H.-P. Kiem, R. Kaul, and D. W. Russell
Foamy virus vector integration sites in normal human cells
PNAS, January 31, 2006; 103(5): 1498 - 1503.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
F. Delebecque, R. Suspene, S. Calattini, N. Casartelli, A. Saib, A. Froment, S. Wain-Hobson, A. Gessain, J.-P. Vartanian, and O. Schwartz
Restriction of Foamy Viruses by APOBEC Cytidine Deaminases
J. Virol., January 15, 2006; 80(2): 605 - 614.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
S. Omoto and Y. R. Fujii
Regulation of human immunodeficiency virus 1 transcription by nef microRNA
J. Gen. Virol., March 1, 2005; 86(3): 751 - 755.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
G. Trobridge and D. W. Russell
Cell Cycle Requirements for Transduction by Foamy Virus Vectors Compared to Those of Oncovirus and Lentivirus Vectors
J. Virol., March 1, 2004; 78(5): 2327 - 2335.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. Schwantes, U. Truyen, J. Weikel, C. Weiss, and M. Lochelt
Application of Chimeric Feline Foamy Virus-Based Retroviral Vectors for the Induction of Antiviral Immunity in Cats
J. Virol., July 15, 2003; 77(14): 7830 - 7842.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
S. Hatama, K. Otake, S. Omoto, Y. Murase, A. Ikemoto, M. Mochizuki, E. Takahashi, H. Okuyama, and Y. Fujii
Isolation and sequencing of infectious clones of feline foamy virus and a human/feline foamy virus Env chimera
J. Gen. Virol., December 1, 2001; 82(12): 2999 - 3004.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. Yvon-Groussin, P. Mugnier, P. Bertin, M. Grandadam, H. Agut, J. M. Huraux, and V. Calvez
Efficacy of Dideoxynucleosides against Human Foamy Virus and Relationship to Its Reverse Transcriptase Amino Acid Sequence and Structure
J. Virol., August 1, 2001; 75(15): 7184 - 7187.
[Abstract] [Full Text]


Home page
BloodHome page
G. Vassilopoulos, G. Trobridge, N. C. Josephson, and D. W. Russell
Gene transfer into murine hematopoietic stem cells with helper-free foamy virus vectors
Blood, August 1, 2001; 98(3): 604 - 609.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
C. D. Meiering and Maxine L. Linial
Historical Perspective of Foamy Virus Epidemiology and Infection
Clin. Microbiol. Rev., January 1, 2001; 14(1): 165 - 176.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
P. D. Bieniasz and B. R. Cullen
Multiple Blocks to Human Immunodeficiency Virus Type 1 Replication in Rodent Cells
J. Virol., November 1, 2000; 74(21): 9868 - 9877.
[Abstract] [Full Text]


Home page
J. Virol.Home page
J. Tobaly-Tapiero, P. Bittoun, M. Neves, M.-C. Guillemin, C.-H. Lecellier, F. Puvion-Dutilleul, B. Gicquel, S. Zientara, M.-L. Giron, H. de Thé, et al.
Isolation and Characterization of an Equine Foamy Virus
J. Virol., May 1, 2000; 74(9): 4064 - 4073.
[Abstract] [Full Text]


Home page
ASH Education BookHome page
D. A. Williams, A. W. Nienhuis, R. G. Hawley, and F. O. Smith
Gene Therapy 2000
Hematology, January 1, 2000; 2000(1): 376 - 393.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 1999 by the Society for General Microbiology.